Advancing gene therapy development with engineered qPCR data

Development scientists at a leading biopharmaceutical company use quantitative polymerase chain reaction (qPCR) to evaluate the impact of process changes on gene therapy products. These assays are crucial for chemistry, manufacturing, and controls (CMC). However, the team's manual-intensive data workflow significantly limited their throughput and data analysis capabilities.

The biopharma's leadership turned to TetraScience to streamline their qPCR process. The solution employs the Tetra Scientific Data and AI Cloud™ to automatically replatform and engineer the qPCR results into analytics- and AI-ready data.

As a result, the improved workflow:

• Increases assay throughput by up to 6x
• Minimizes manual steps, saving up to 1 hour per assay
• Enables meta-analyses across multiple experiments